Company Overview

PRIME exits and American Healthcare Capital are proud to be the exclusive representative of a high-growth, U.S. based, offshore healthcare staffing and outsourcing company. Founded in 2022, the company specializes in providing HIPAA-compliant virtual staffing and administrative services to U.S. healthcare organizations, including medical billing, coding, scheduling, and EMR integration. The company is well-positioned to offer certified virtual nursing resources very soon.

Financial Overview

The business has scaled rapidly, reaching $1.3 million in revenue in 2024 with a projected $2.1 million for 2025. Profit margins have exceeded 47%, supported by a 63-person offshore team and zero in-office overhead. The company operates with a lean infrastructure, having grown exclusively through client referrals and without sales or marketing costs.

The seller is the sole founder and operator and seeks a strategic or capital partner to purchase a majority interest (60–75%) at a $4 million valuation., with a rollover of minority equity. The founder is open to remaining in an operational or advisory role and has a strong management layer already in place, ensuring business continuity post-transaction.  

This company serves a growing demand in the U.S. healthcare system—helping providers combat labor shortages, rising costs, and administrative inefficiencies. It is ideally positioned for buyers focused on platform growth in revenue cycle management, healthcare BPO, healthcare staffing or private equity roll-up strategies.

Key investment highlights include:

• Scalable offshore infrastructure

• No dependency on government payors (100% cash clients)

• High gross and EBITDA margins

• Strong retention and organic growth

• Sector with 10% CAGR growth to 2030

Deal Structure and Asking Price

The transaction involves selling 60 to 75 percent ownership in the company at a $4 million valuation. The Founder will keep a minority stake and collaborate with the new partner for long-term growth. The asking price excludes cash, accounts receivable, and working capital, which will be retained by the seller. An earn-out is highly desirable above the current valuation to provide buyer flexibility and align with the Founder’s ongoing involvement and incentive for further growth.

This is a strategic opportunity to acquire a high-margin, recession-resilient business that addresses one of the most urgent challenges in healthcare today: operational efficiency. For serious inquiries only. NDA and seller approval are required before circulating the Confidential Information Memorandum (CIM).